Alpha-interferon in chronic myelogenous leukaemia.
作者信息
Kumar L, Gulati S C
机构信息
Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
出版信息
Lancet. 1995 Oct 14;346(8981):984-6. doi: 10.1016/s0140-6736(95)91683-0.
PMID:7475589
Abstract
摘要
相似文献
1
Alpha-interferon in chronic myelogenous leukaemia.
Lancet. 1995 Oct 14;346(8981):984-6. doi: 10.1016/s0140-6736(95)91683-0.
2
[Interferon-alpha therapy in chronic myelogenous leukemia].
Rinsho Ketsueki. 2000 Apr;41(4):275-9.
3
The adverse influence of pretransplant interferon-alpha (IFN-alpha) on transplant outcome after marrow transplantation for chronic phrase chronic myelogenous leukemia increases with the duration of IFN-alpha exposure.对于慢性期慢性粒细胞白血病患者，移植前使用α干扰素（IFN-α）对骨髓移植后移植结果的不良影响会随着IFN-α暴露时间的延长而增加。
Blood. 1999 Mar 1;93(5):1779-10.
4
Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.当前关于α干扰素在慢性髓性白血病治疗中作用的争议。
Bone Marrow Transplant. 1996 May;17 Suppl 3:S39.
5
Chronic myeloid leukemia.慢性髓系白血病
N Engl J Med. 1999 Apr 29;340(17):1330-40. doi: 10.1056/NEJM199904293401706.
6
7
[Interferon-alpha in the treatment of chronic myeloid leukemia].[干扰素-α治疗慢性髓性白血病]
Rev Prat. 1999 Mar 1;49(5):464-6.
8
[Therapy of chronic myeloid leukemia].[慢性髓性白血病的治疗]
Internist (Berl). 1993 Jun;34(6):542-9.
9
NCCN Practice Guidelines for Chronic Myelogenous Leukemia.美国国立综合癌症网络慢性髓性白血病临床实践指南
Oncology (Williston Park). 2000 Nov;14(11A):229-40.
10
Chronic myeloid leukemia. Introduction.
Am J Health Syst Pharm. 2007 Dec 15;64(24 Suppl 15):S2-3. doi: 10.2146/ajhp070485.
Zotero 插件